A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Impact in
- Neurology 61
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/s41591-023-02788-5 →Countries where authors are citing A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
This map shows the geographic impact of A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD more than expected).
Fields of papers citing A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
This network shows the impact of A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD.
About A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
This paper, published in 2024, received 88 indexed citations . Written by Katherine E. Irwin, Kerstin E. Braunstein, Irika R. Sinha, Koping Chang, Juan Carlos Troncoso, Abhay Moghekar, Esther S. Oh, Denitza Raitcheva, Timothy M. Miller and James D. Berry covering the research area of Neurology, Genetics and Molecular Biology. It is primarily cited by scholars working on Neurology (61 citations), Molecular Biology (29 citations), Genetics (29 citations), Physiology (14 citations) and Neurology (9 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/s41591-023-02788-5.